Phenylacetyl glutamine (PAGln) enhances cardiomyocyte death after myocardial infarction through β1 adrenergic receptor.

Xu H, Yang N, Wang BY, Zhou L, Xu LL, Chen Y, Wang DJ, Ge WH

Open source

DOI
10.1002/tox.24063
Published
2024 Mar
Container
Environmental toxicology
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/tox.24063,
  title = {Phenylacetyl glutamine (PAGln) enhances cardiomyocyte death after myocardial infarction through β1 adrenergic receptor.},
  author = {Xu H and Yang N and Wang BY and Zhou L and Xu LL and Chen Y and Wang DJ and Ge WH},
  year = {2024},
  journal = {Environmental toxicology},
  doi = {10.1002/tox.24063},
  url = {https://doi.org/10.1002/tox.24063}
}

RIS

TY  - JOUR
TI  - Phenylacetyl glutamine (PAGln) enhances cardiomyocyte death after myocardial infarction through β1 adrenergic receptor.
AU  - Xu H
AU  - Yang N
AU  - Wang BY
AU  - Zhou L
AU  - Xu LL
AU  - Chen Y
AU  - Wang DJ
AU  - Ge WH
PY  - 2024
JO  - Environmental toxicology
DO  - 10.1002/tox.24063
UR  - https://doi.org/10.1002/tox.24063
ER  - 

APA

H, X., N, Y., BY, W., L, Z., LL, X., Y, C., DJ, W., & WH, G. (2024). Phenylacetyl glutamine (PAGln) enhances cardiomyocyte death after myocardial infarction through β1 adrenergic receptor.. Environmental toxicology. https://doi.org/10.1002/tox.24063

Source records